MONELL CHEMICAL SENSES CENTER

Advancing Discovery in Taste and Smell

aka The Monell Center | Philadelphia, PA | www.monell.org

Donate

GuideStar Charity Check

EIN: 23-2020897

Contributions tax deductible
as of March 2023

IRS BMF 509(a)(1)
as of March 13, 2023

View summary

Charity Check report

Mission

Monell’s mission is to improve health and well-being by advancing the scientific understanding of taste, smell, and related senses.

Ruling year info

1977

Acting Director & President

Dr. Nancy E. Rawson M.Sc., Ph.D., FCPP

Main address

3500 Market Street

Philadelphia, PA 19104 USA

Show more contact info

EIN

23-2020897

Subject area info

Medical specialties

Biochemistry

Population served info

Adolescents

Adults

NTEE code info

Medical Specialty Research (H90)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Show Forms 990

Communication

Blog

Programs and results

Reports and documents

What we aim to solve

SOURCE: Self-reported by organization

Imagine a future in which physicians use hand-held odor detectors to sniff out the earliest signs of cancer with the same uncanny accuracy that dogs have for detecting bombs and narcotics. Consider the prospect of being able to "train" human taste receptors -- not just on the tongue but in the gut, pancreas and brain -- to promote healthy eating and help curb obesity. Fast forward to a day when we can replace damaged or aging smell receptors in the nose to restore our ability to fully enjoy the wonderful scent of newborns and tantalizing flavors of our favorite foods. These future scenarios are closer than you might think. This is the Monell Center, the only research institute dedicated to understanding the senses of taste and smell, and connecting these fundamental senses to improved nutrition, disease detection and other translations of our basic science to provide a healthier, safer, better tomorrow.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Basic Science at Monell

Mission
Monell’s mission is to improve health and well-being by advancing the scientific understanding of taste, smell, and related senses.

Core Values
Commitment: We view basic science as the foundation of discovery

An integral part of Monell’s mission involves preparation of the next generation of scientists. Monell’s strong post-doctoral program attracts talented young scientists from a wide range of disciplines. Approximately 20 post-doctoral fellows are trained at the Center each year. Monell fellows go on to contribute to scientific advancement through work in academia, industry and government.

The Center’s highly successful Monell Science Apprenticeship Program (MSAP) for high school and college students is now entering its 34th year. The program aims to stimulate interest in STEM careers among demographic groups underrepresented in science, including females, racial and ethnic minorities, and the economically disadvantaged. MSAP enrolls approximately 25 students each summer.

Population(s) Served

Adults

Adolescents

Where we work

External reviews

Photos

Videos

Goals & Strategy

SOURCE: Self-reported by organization

Reports and documents

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

What is the organization aiming to accomplish?

The Monell Center has 4 strategic aims:

1. Improve Nutritional Health
2. Diagnose and Treat Diseases
3. Attach the Loss of Smell and Taste
4. Digitize Smells and Tastes

What are the organization's key strategies for making this happen?

To unravel these complex interwoven processes, the Center is structured to encourage collaboration among scientists from diverse backgrounds. The Monell Center has no departmental organization; offices and laboratories are not segregated by discipline; and most importantly, the staff is imbued with the ideal of multidisciplinary interaction.

What are the organization's capabilities for doing this?

Among the Center's unique areas of expertise:

• Human sensory testing across the lifespan using innovative psychophysical and physiological techniques
• Integration of human sensory perception with molecular biology
• Pioneering techniques to biopsy and maintain living human taste and smell receptor cells for human species-specific study
• Experiential, physiological and genetic determinants of flavor and food preferences across the lifespan
• Stem cell biology to regenerate dysfunctional taste and smell receptor cells
• Focus on taste and smell receptors in extra-oral sites and their relation to health
• Odor communication in health and disease

What have they accomplished so far and what's next?

The Center's research advances fundamental knowledge of taste and smell. In the process, Monell's scientific findings also uncover solutions to pressing problems related to health, the environment and more. Monell scientists helped to identify the sweet taste receptor, a breakthrough that paved the way to current inquiries into how to stimulate, manipulate, enhance, inhibit, and create synergy of sweet taste. In other areas, ongoing Monell research is:

• Demonstrating the key role of prenatal and early postnatal experience in shaping life-long taste, odor, and flavor preferences.
• Utilizing advanced stem cell biology techniques to regenerate smell receptors and develop treatments for smell loss.
• Analyzing the genetics of taste to identify the salt taste receptor, knowledge needed to develop effective salt enhancers and modifiers and help reduce sodium consumption.
• Identifying how body odors can be used for the early non-invasive detection and diagnosis of cancer, infectious disease, and tissue damage.
• Determining how genetic variation in taste and smell receptors influences flavor perception, food choice, nutrition, and health across the lifespan.
• Pioneering studies of odortypes, genetically-determined olfactory markers of individual identity.
• Revealing how short and long-term exposure to air-borne chemicals alter sensory perception and health.
• Probing the mechanism and function of taste and smell receptors located outside the mouth and nose.

Financials

MONELL CHEMICAL SENSES CENTER

Fiscal year: Jul 01 - Jun 30

Financial documents

Yes, financials were audited by an independent accountant.

Revenue vs. expenses: breakdown

SOURCE: IRS Form 990

NET GAIN/LOSS: in

Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2020

SOURCE: IRS Form 990

0.77

Average of 1.08 over 10 years

Months of cash in 2020

SOURCE: IRS Form 990

0.5

Average of 2 over 10 years

Fringe rate in 2020

SOURCE: IRS Form 990

23%

Average of 24% over 10 years

Funding sources

Source: IRS Form 990

Assets & liabilities

Source: IRS Form 990

Financial data

Source: IRS Form 990

Digitizing IRS form 990 data

MONELL CHEMICAL SENSES CENTER

Revenue & expenses

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990

Fiscal year ending: Download Data

Revenue
Contributions	$7,653,773
Government Grants	$6,368,570
Program Services	$0
Investments	$75,586
Special Events	$0
Sales	$0
Other	$200,957
Total Revenue	$14,298,886

Expenses
Program Services	$13,116,940
Administration	$2,177,986
Fundraising	$619,436
Total Expenses	$15,914,362
Net Gain/Loss	($1,615,476)

Functional expenses
Accounting Fees	$46,864
Advertising & Promotion	$0
Information Technology Expenses	$49,064
Insurance Expenses	$242,891
Interest Expenses	$201,618
Investment Management Fees	$16,323
Legal Fees	$200,277
Pension Plan Contributions	$424,899
Professional Fundraising Expenses	$25,958

Revenue
Contributions	$6,560,554
Government Grants	$7,270,032
Program Services	$0
Investments	$82,441
Special Events	$0
Sales	$0
Other	$76,500
Total Revenue	$13,989,527

Expenses
Program Services	$11,211,782
Administration	$2,098,321
Fundraising	$599,653
Total Expenses	$13,909,756
Net Gain/Loss	$79,771

Functional expenses
Accounting Fees	$62,323
Advertising & Promotion	$0
Information Technology Expenses	$74,993
Insurance Expenses	$227,711
Interest Expenses	$193,713
Investment Management Fees	$14,908
Legal Fees	$94,538
Pension Plan Contributions	$142,329
Professional Fundraising Expenses	$12,591

Revenue
Contributions	$7,422,299
Government Grants	$8,251,961
Program Services	$0
Investments	$91,236
Special Events	$0
Sales	$0
Other	$214,186
Total Revenue	$15,979,682

Expenses
Program Services	$12,309,385
Administration	$2,473,944
Fundraising	$618,293
Total Expenses	$15,401,622
Net Gain/Loss	$578,060

Functional expenses
Accounting Fees	$57,904
Advertising & Promotion	$0
Information Technology Expenses	$176,224
Insurance Expenses	$216,188
Interest Expenses	$185,375
Investment Management Fees	$16,946
Legal Fees	$129,533
Pension Plan Contributions	$245,583
Professional Fundraising Expenses	$13,184

Revenue
Contributions	$6,629,667
Government Grants	$9,990,524
Program Services	$0
Investments	$94,271
Special Events	$0
Sales	$0
Other	$132,432
Total Revenue	$16,846,894

Expenses
Program Services	$13,167,463
Administration	$2,672,401
Fundraising	$530,112
Total Expenses	$16,369,976
Net Gain/Loss	$476,918

Functional expenses
Accounting Fees	$78,385
Advertising & Promotion	$0
Information Technology Expenses	$90,750
Insurance Expenses	$217,933
Interest Expenses	$177,062
Investment Management Fees	$17,264
Legal Fees	$161,974
Pension Plan Contributions	$295,321
Professional Fundraising Expenses	$8,673

Revenue
Contributions	$5,949,366
Government Grants	$10,271,804
Program Services	$0
Investments	$74,635
Special Events	$0
Sales	$0
Other	$377,027
Total Revenue	$16,672,832

Expenses
Program Services	$13,168,515
Administration	$2,716,605
Fundraising	$739,168
Total Expenses	$16,624,288
Net Gain/Loss	$48,544

Functional expenses
Accounting Fees	$63,728
Advertising & Promotion	$0
Information Technology Expenses	$125,272
Insurance Expenses	$225,129
Interest Expenses	$167,322
Investment Management Fees	$28,787
Legal Fees	$131,009
Pension Plan Contributions	$333,286
Professional Fundraising Expenses	$16,005

Revenue
Contributions	$7,736,298
Government Grants	$6,693,991
Program Services	$0
Investments	$56,251
Special Events	$0
Sales	$0
Other	$401,405
Total Revenue	$14,887,945

Expenses
Program Services	$11,743,753
Administration	$2,722,668
Fundraising	$726,056
Total Expenses	$15,192,477
Net Gain/Loss	($304,532)

Functional expenses
Accounting Fees	$60,061
Advertising & Promotion	$0
Information Technology Expenses	$61,706
Insurance Expenses	$233,152
Interest Expenses	$157,532
Investment Management Fees	$32,297
Legal Fees	$122,800
Pension Plan Contributions	$321,205
Professional Fundraising Expenses	$0

Revenue
Contributions	$8,229,400
Government Grants	$6,335,761
Program Services	$0
Investments	$125,315
Special Events	$0
Sales	$0
Other	$160,246
Total Revenue	$14,850,722

Expenses
Program Services	$11,377,711
Administration	$2,654,264
Fundraising	$776,970
Total Expenses	$14,808,945
Net Gain/Loss	$41,777

Functional expenses
Accounting Fees	$49,732
Advertising & Promotion	$0
Information Technology Expenses	$120,630
Insurance Expenses	$237,118
Interest Expenses	$147,205
Investment Management Fees	$23,947
Legal Fees	$77,144
Pension Plan Contributions	$317,957
Professional Fundraising Expenses	$0

Revenue
Contributions	$7,681,087
Government Grants	$5,208,517
Program Services	$0
Investments	$85,429
Special Events	$0
Sales	$0
Other	$151,993
Total Revenue	$13,127,026

Expenses
Program Services	$10,775,011
Administration	$2,634,504
Fundraising	$856,605
Total Expenses	$14,266,120
Net Gain/Loss	($1,139,094)

Functional expenses
Accounting Fees	$67,714
Advertising & Promotion	$0
Information Technology Expenses	$118,766
Insurance Expenses	$240,254
Interest Expenses	$149,580
Investment Management Fees	$24,062
Legal Fees	$113,106
Pension Plan Contributions	$319,155
Professional Fundraising Expenses	$50,045

Revenue
Contributions	$7,955,270
Government Grants	$3,558,005
Program Services	$0
Investments	$64,162
Special Events	$0
Sales	$0
Other	$187,010
Total Revenue	$11,764,447

Expenses
Program Services	$9,729,217
Administration	$2,697,477
Fundraising	$915,902
Total Expenses	$13,342,596
Net Gain/Loss	($1,578,149)

Functional expenses
Accounting Fees	$66,973
Advertising & Promotion	$0
Information Technology Expenses	$120,358
Insurance Expenses	$217,938
Interest Expenses	$113,645
Investment Management Fees	$21,449
Legal Fees	$44,308
Pension Plan Contributions	$292,405
Professional Fundraising Expenses	$18,600

Revenue
Contributions	$8,784,758
Government Grants	$4,045,485
Program Services	$0
Investments	$30,818
Special Events	$0
Sales	$0
Other	$113,415
Total Revenue	$12,974,476

Expenses
Program Services	$9,335,173
Administration	$2,591,385
Fundraising	$801,519
Total Expenses	$12,728,077
Net Gain/Loss	$246,399

Functional expenses
Accounting Fees	$71,086
Advertising & Promotion	$0
Information Technology Expenses	$105,970
Insurance Expenses	$220,821
Interest Expenses	$106,310
Investment Management Fees	$18,175
Legal Fees	$115,438
Pension Plan Contributions	$231,885
Professional Fundraising Expenses	$6,900

Revenue
Contributions	$8,662,392
Government Grants	$4,970,469
Program Services	$0
Investments	$61,894
Special Events	($29,296)
Sales	$0
Other	$90,363
Total Revenue	$13,755,822

Expenses
Program Services	$9,704,376
Administration	$2,635,685
Fundraising	$868,073
Total Expenses	$13,208,134
Net Gain/Loss	$547,688

Functional expenses
Accounting Fees	$72,823
Advertising & Promotion	$0
Information Technology Expenses	$135,267
Insurance Expenses	$201,927
Interest Expenses	$96,781
Investment Management Fees	$17,965
Legal Fees	$110,623
Pension Plan Contributions	$228,847
Professional Fundraising Expenses	$12,154

Revenue
Contributions	$7,196,986
Government Grants	$5,058,061
Program Services	$0
Investments	$170,185
Special Events	$0
Sales	$0
Other	$53,451
Total Revenue	$12,478,683

Expenses
Program Services	$10,088,460
Administration	$2,342,350
Fundraising	$901,598
Total Expenses	$13,332,408
Net Gain/Loss	($853,725)

Functional expenses
Accounting Fees	$42,974
Advertising & Promotion	$0
Information Technology Expenses	$101,924
Insurance Expenses	$203,941
Interest Expenses	$116,587
Investment Management Fees	$17,815
Legal Fees	$40,727
Pension Plan Contributions	$259,756
Professional Fundraising Expenses	$0

MONELL CHEMICAL SENSES CENTER

Balance sheet

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: Download Data

Assets	Jul 01, 2008	Jun 30, 2009	Change
Contributions	$7,653,773
Cash & Equivalents	$1,754,164	$1,996,778	$242,614
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$2,855,325	$2,371,867	($483,458)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$2,471,684	$1,687,207	($784,477)
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$18,304,779	$17,867,579	($437,200)
Other	$284,458	$165,929	($118,529)
Total Assets	$25,670,410	$24,089,360	($1,581,050)

Liabilities	Jul 01, 2008	Jun 30, 2009	Change
Accounts Payable	$363,946	$377,329	$13,383
Grants Payable	$2,620,717	$0	($2,620,717)
Deferred Revenue	$0	$2,798,167	$2,798,167
Loans and Notes	$3,823,952	$3,680,163	($143,789)
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$6,808,615	$6,855,659	$47,044

Fund balance	Jul 01, 2008	Jun 30, 2009	Change
Temporarily Restricted Net Assets	$0	$0	$0
Permanently Restricted Net Assets	$0	$0	$0
Total Restricted Net Assets	$0	$0	$0
Unrestricted Net Assets	$18,861,795	$17,233,701	($1,628,094)
Net Assets	$18,861,795	$17,233,701	($1,628,094)

Assets	Jul 01, 2009	Jun 30, 2010	Change
Contributions	$6,560,554
Cash & Equivalents	$1,996,778	$1,635,862	($360,916)
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$2,371,867	$2,152,682	($219,185)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$1,687,207	$2,773,136	$1,085,929
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$17,867,579	$17,358,494	($509,085)
Other	$165,929	$209,645	$43,716
Total Assets	$24,089,360	$24,129,819	$40,459

Liabilities	Jul 01, 2009	Jun 30, 2010	Change
Accounts Payable	$377,329	$255,668	($121,661)
Grants Payable	$0	$0	$0
Deferred Revenue	$2,798,167	$2,975,290	$177,123
Loans and Notes	$3,680,163	$3,528,469	($151,694)
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$6,855,659	$6,759,427	($96,232)

Fund balance	Jul 01, 2009	Jun 30, 2010	Change
Temporarily Restricted Net Assets	$0	$347	$347
Permanently Restricted Net Assets	$0	$38,608	$38,608
Total Restricted Net Assets	$0	$38,955	$38,955
Unrestricted Net Assets	$17,233,701	$17,331,437	$97,736
Net Assets	$17,233,701	$17,370,392	$136,691

Assets	Jul 01, 2010	Jun 30, 2011	Change
Contributions	$7,422,299
Cash & Equivalents	$1,635,862	$2,086,991	$451,129
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$2,152,682	$2,069,075	($83,607)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$2,773,136	$3,840,532	$1,067,396
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$17,358,494	$16,822,760	($535,734)
Other	$209,645	$263,585	$53,940
Total Assets	$24,129,819	$25,082,943	$953,124

Liabilities	Jul 01, 2010	Jun 30, 2011	Change
Accounts Payable	$255,668	$234,624	($21,044)
Grants Payable	$0	$0	$0
Deferred Revenue	$2,975,290	$3,576,577	$601,287
Loans and Notes	$3,528,469	$3,368,436	($160,033)
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$6,759,427	$7,179,637	$420,210

Fund balance	Jul 01, 2010	Jun 30, 2011	Change
Temporarily Restricted Net Assets	$347	$92,825	$92,478
Permanently Restricted Net Assets	$38,608	$38,608	$0
Total Restricted Net Assets	$38,955	$131,433	$92,478
Unrestricted Net Assets	$17,331,437	$17,771,873	$440,436
Net Assets	$17,370,392	$17,903,306	$532,914

Assets	Jul 01, 2011	Jun 30, 2012	Change
Contributions	$6,629,667
Cash & Equivalents	$2,086,991	$2,930,898	$843,907
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$2,069,075	$1,585,923	($483,152)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$3,840,532	$4,140,747	$300,215
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$16,822,760	$16,271,248	($551,512)
Other	$263,585	$212,397	($51,188)
Total Assets	$25,082,943	$25,141,213	$58,270

Liabilities	Jul 01, 2011	Jun 30, 2012	Change
Accounts Payable	$234,624	$297,473	$62,849
Grants Payable	$0	$0	$0
Deferred Revenue	$3,576,577	$3,229,728	($346,849)
Loans and Notes	$3,368,436	$3,200,090	($168,346)
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$7,179,637	$6,727,291	($452,346)

Fund balance	Jul 01, 2011	Jun 30, 2012	Change
Temporarily Restricted Net Assets	$92,825	$46,795	-$46,030
Permanently Restricted Net Assets	$38,608	$38,608	$0
Total Restricted Net Assets	$131,433	$85,403	($46,030)
Unrestricted Net Assets	$17,771,873	$18,328,519	$556,646
Net Assets	$17,903,306	$18,413,922	$510,616

Assets	Jul 01, 2012	Jun 30, 2013	Change
Contributions	$5,949,366
Cash & Equivalents	$2,930,898	$3,039,230	$108,332
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$1,585,923	$1,943,590	$357,667
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$4,140,747	$5,336,104	$1,195,357
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$16,271,248	$15,628,166	($643,082)
Other	$212,397	$246,298	$33,901
Total Assets	$25,141,213	$26,193,388	$1,052,175

Liabilities	Jul 01, 2012	Jun 30, 2013	Change
Accounts Payable	$297,473	$270,369	($27,104)
Grants Payable	$0	$0	$0
Deferred Revenue	$3,229,728	$4,474,217	$1,244,489
Loans and Notes	$3,200,090	$3,022,005	($178,085)
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$6,727,291	$7,766,591	$1,039,300

MONELL CHEMICAL SENSES CENTER

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990

This snapshot of MONELL CHEMICAL SENSES CENTER’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Fiscal year: Jul 01 - Jun 30 View full report Download data

Business model indicators

Profitability	2016	2017	2018	2019	2020
Unrestricted surplus (deficit) before depreciation	$41,702	-$855,630	-$208,613	$350,135	-$574,478
As % of expenses	0.3%	-6.9%	-1.8%	2.9%	-4.6%
Unrestricted surplus (deficit) after depreciation	-$956,133	-$1,854,918	-$1,161,101	-$609,623	-$1,549,922
As % of expenses	-6.7%	-13.9%	-9.1%	-4.6%	-11.6%

Revenue composition
Total revenue (unrestricted & restricted)	$13,127,026	$11,764,447	$12,974,476	$13,755,822	$12,478,683
Total revenue, % change over prior year	-11.6%	-10.4%	10.3%	6.0%	-9.3%
Program services revenue	0.0%	0.0%	0.0%	0.0%	0.0%
Membership dues	0.0%	0.0%	0.0%	0.0%	0.0%
Investment income	1.5%	1.3%	0.9%	0.9%	0.9%
Government grants	39.7%	30.2%	31.2%	36.1%	40.5%
All other grants and contributions	58.5%	67.6%	67.7%	62.8%	57.7%
Other revenue	0.3%	0.8%	0.2%	0.3%	0.9%

Expense composition
Total expenses before depreciation	$13,268,285	$12,343,308	$11,775,589	$12,248,376	$12,356,964
Total expenses, % change over prior year	-3.5%	-7.0%	-4.6%	4.0%	0.9%
Personnel	67.8%	67.8%	65.1%	65.6%	68.0%
Professional fees	2.3%	1.5%	2.5%	2.6%	1.4%
Occupancy	8.2%	8.4%	8.7%	8.4%	8.1%
Interest	1.1%	0.9%	0.9%	0.8%	0.9%
Pass-through	0.0%	0.0%	0.0%	0.0%	0.0%
All other expenses	20.6%	21.4%	22.9%	22.6%	21.6%

Full cost components (estimated)	2016	2017	2018	2019	2020
Total expenses (after depreciation)	$14,266,120	$13,342,596	$12,728,077	$13,208,134	$13,332,408
One month of savings	$1,105,690	$1,028,609	$981,299	$1,020,698	$1,029,747
Debt principal payment	$0	$509,774	$521,897	$534,691	$0
Fixed asset additions	$1,474,037	$0	$1,028,365	$0	$0
Total full costs (estimated)	$16,845,847	$14,880,979	$15,259,638	$14,763,523	$14,362,155

Capital structure indicators

Liquidity	2016	2017	2018	2019	2020
Months of cash	3.0	2.6	0.8	1.1	0.5
Months of cash and investments	8.1	6.8	5.0	5.4	4.5
Months of estimated liquid unrestricted net assets	5.7	4.8	3.2	2.7	1.7

Balance sheet composition	2016	2017	2018	2019	2020
Cash	$3,277,549	$2,707,062	$798,375	$1,152,807	$562,560
Investments	$5,634,142	$4,302,560	$4,066,238	$4,311,407	$4,095,484
Receivables	$800,303	$1,313,096	$1,865,859	$2,214,025	$4,733,087
Gross land, buildings, equipment (LBE)	$34,678,591	$34,782,095	$35,791,096	$35,776,510	$36,074,418
Accumulated depreciation (as a % of LBE)	57.6%	60.4%	61.3%	63.4%	65.4%
Liabilities (as a % of assets)	30.1%	29.6%	23.4%	20.4%	27.4%
Unrestricted net assets	$17,169,655	$15,314,737	$14,153,636	$13,544,013	$11,994,091
Temporarily restricted net assets	$4,054	$355,346	$1,786,664	$3,149,285	N/A
Permanently restricted net assets	$43,608	$43,608	$43,608	$43,608	N/A
Total restricted net assets	$47,662	$398,954	$1,830,272	$3,192,893	$4,001,889
Total net assets	$17,217,317	$15,713,691	$15,983,908	$16,736,906	$15,995,980

Key data checks

Key data checks	2016	2017	2018	2019	2020
Material data errors	No	No	No	No	No

Operations

The people, governance practices, and partners that make the organization tick.

Documents

Letter of Determination

Form 1023/1024 is not available for this organization

Acting Director & President

Dr. Nancy E. Rawson M.Sc., Ph.D., FCPP

LinkedIn profile

Before becoming Monell's Acting Director & President in July 2022, Dr. Rawson had served as the Center’s Associate Director since 2016 and Vice President since 2019, leading the corporate program while also spearheading the crafting and implementation of its new strategic plan. Her broad research and administrative experience includes stints in both academia and the food, flavor, and nutritional products industries. She received her doctorate in biology from the University of Pennsylvania in 1993. After postdoctoral training at Monell, she joined the Center’s faculty, where she remained for the next 15 years. In 2008, Rawson left Monell to become chief scientific officer at a nutrigenomics start-up company. Later, she served as Senior Director of Basic Research and Innovation at AFB International, a global pet food ingredient firm, before returning to Monell.

Number of employees

Source: IRS Form 990

MONELL CHEMICAL SENSES CENTER

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of officer and director compensation data for this organization

MONELL CHEMICAL SENSES CENTER

Highest paid employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of highest paid employee data for this organization

MONELL CHEMICAL SENSES CENTER

Board of directors
as of 02/21/2023

SOURCE: Self-reported by organization

Board of directors data

Download the most recent year of board of directors data for this organization

Board chair

Dr. David Macnair

Independent Consultant

Richard Berkman

Ambrose Monell

The Ambrose Monell Foundation & the G. Under Vetlesen Foundation

Maurizio Morello

Fulton Vittoria LLP

David MacNair

Stephen Manheimer

Kerry

Kevin Foskett

Perelman School of Medicine, University of Pennsylvania

Paul Herzan

Vice President and Director, Lily Auchincloss Foundation

Angela Nwaneri

First Cardiology Consultants/FCC Healthcare

Judy Wellington

Nancy Rawson

Monell Chemical Senses Center

Susan de Mars

US Pharmacopeia

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? No
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? No
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 2/21/2023

Candid has made improvements to the race and ethnicity options.

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity

Decline to state

Sexual orientation

Decline to state

Disability status

Decline to state

Race & ethnicity

Gender identity

Sexual orientation

No data

Disability

No data

Equity strategies

Last updated: 01/18/2022

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

Policies and processes

We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
We have community representation at the board level, either on the board itself or through a community advisory board.
We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.

Contractors

Fiscal year ending

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities

Gross receipts from fundraising

Retained by organization

Paid to fundraiser

MONELL CHEMICAL SENSES CENTER

Advancing Discovery in Taste and Smell

Mission

Is this your nonprofit?

Programs and results

Reports and documents

What we aim to solve

Our programs

Basic Science at Monell

Where we work

Goals & Strategy

Reports and documents

Charting impact

What is the organization aiming to accomplish?

What are the organization's key strategies for making this happen?

What are the organization's capabilities for doing this?

What have they accomplished so far and what's next?

Financials

Financial documents

Revenue vs. expenses: breakdown

Liquidity in 2020 info

0.77

Months of cash in 2020 info

0.5

Fringe rate in 2020 info

23%

Funding sources info

Assets & liabilities info

Financial data

Digitizing IRS form 990 data

MONELL CHEMICAL SENSES CENTER

MONELL CHEMICAL SENSES CENTER

MONELL CHEMICAL SENSES CENTER

Business model indicators

Capital structure indicators

Key data checks

Operations

Documents

Acting Director & President

Dr. Nancy E. Rawson M.Sc., Ph.D., FCPP

Number of employees

MONELL CHEMICAL SENSES CENTER

Compensation data

MONELL CHEMICAL SENSES CENTER

Compensation data

MONELL CHEMICAL SENSES CENTER

Board of directors data

Dr. David Macnair

Board leadership practices

Board orientation and education

CEO oversight

Ethics and transparency

Board composition

Board performance

Organizational demographics

Leadership

Race & ethnicity

Gender identity

Sexual orientation

Disability

Equity strategies

Contractors

Professional fundraisers

Solicitation activities

Liquidity in 2020

Months of cash in 2020

Fringe rate in 2020

Funding sources

Assets & liabilities